Filing Details

Accession Number:
0000950142-15-002434
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-16 17:16:36
Reporting Period:
2015-11-12
Filing Date:
2015-11-16
Accepted Time:
2015-11-16 17:16:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581720 Loxo Oncology Inc. LOXO Pharmaceutical Preparations (2834) 462996673
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1172252 N Andrew Schiff 888 Seventh Avenue, 12Th Floor
New York NY 10106
No No Yes No
1250195 Steve Elms 888 Seventh Avenue
12Th Floor
New York NY 10106
Yes No Yes No
1297291 J Dennis Purcell 888 Seventh Avenue, 12Th Floor
New York NY 10106
No No Yes No
1444717 Aisling Capital Iii Lp 888 Seventh Avenue, 12Th Floor
New York NY 10106
No No Yes No
1532634 Aisling Capital Partners Iii Lp Aisling Capital Llc
888 Seventh Avenue 12Th Floor
New York NY 10106
No No Yes No
1532635 Aisling Capital Partners Iii Llc Aisling Capital Llc
888 Seventh Avenue 12Th Floor
New York NY 10106
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-12 76,714 $27.65 3,529,207 No 4 P Direct
Common Stock Acquisiton 2015-11-13 1,955 $27.47 3,531,182 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The securities are directly held by Aisling Capital III, LP ("Aisling"), and indirectly held by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Mr. Elms is a member of the Issuer's Board of Directors. Dr. Joshua Bilenker, the Issuer's President and Chief Executive Officer, is a member of the Issuer's Board of Directors and an Operating Partner of Aisling GP. Mr. Elms is a member of the investment committee (the "Investment Committee") of Aisling GP. The Investment Committee has voting and dispositive power over the shares held by Aisling.